KTC
PDSB icon

Kistler-Tiffany Companies’s PDS Biotechnology PDSB Stock Holding History

Kistler-Tiffany Companies’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-57
Closed -$10K – 520
2017
Q1 		$10K Hold
57
– – ﹤0.01% 400
2016
Q4 		$14K Hold
57
– – 0.01% 386
2016
Q3 		$12K Hold
57
– – 0.01% 417
2016
Q2 		$12K Buy
+57
New +$10.1K 0.01% 417

Other funds holding PDSB

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kistler-Tiffany Companies's PDSB Position: Q2 2017 in Review

Kistler-Tiffany Companies sold out of PDS Biotechnology (PDSB) in Q2 2017, closing a stake of 57 shares — an estimated $10K sold.

Kistler-Tiffany Companies first reported a position in PDSB in Q2 2016 and held it in 4 quarters. The position peaked at $14K in Q4 2016. 54 funds tracked by Wall St. Rank hold PDSB as of Q2 2017.

  • Kistler-Tiffany Companies reported no remaining PDS Biotechnology position as of Q2 2017 after selling out during the quarter.
  • Kistler-Tiffany Companies sold 57 PDS Biotechnology shares in Q2 2017, an estimated $10K.
  • Kistler-Tiffany Companies first reported a position in PDS Biotechnology in Q2 2016 and held it in 4 quarters.
  • Kistler-Tiffany Companies's PDS Biotechnology position peaked at $14K in Q4 2016.
  • 54 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2017.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2017, filed 28 Jul 2017.